Tender detail

Open-house rebate agreements for biologic medicines 2026-08 – Filgrastim

Summary

The participating health insurers are seeking rebate agreements with pharmaceutical companies for the active substance filgrastim through an open-house procedure. The agreements have uniform terms, do not grant exclusivity and may run for up to 24 months, from 1 May 2026 at the earliest until 30 April 2028 at the latest. Companies may join the procedure at any time during the contract period.

Reference number
094707a6-8573-499f-82fe-5b92c8af3ad2
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-04-30
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.